Mesalamine Delayed-Release Tablets, USP, 1.2 gram, 120-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054; NDC 0591-2245-22.
Published March 11, 2020 · Recall initiated: February 20, 2020
Summary
FDA records drug Class II recall D-0862-2020, published March 11, 2020 and initiated February 20, 2020. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 3,695 bottles; Lot: Lot #: 1342500A, Exp 10/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: Low out of specification dissolution result observed during stability testing.
What to do
Voluntary: Firm initiated · Letter
Get an email if MESALAMINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MESALAMINE
- Manufacturer
- Teva Pharmaceuticals USA
- Distributor
- Nationwide in the USA.
- UPC
- 0305912245229
- Lot
- Lot #: 1342500A, Exp 10/2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMesalamine Extended-Release Capsules, USP 500mg, Rx Only, 120 Capsules per bottle, Manufactured by: SunMarch 6, 2024
- FDAMesalamine Delayed-Release Tablets, USP 1.2 g per tablet, Rx Only, 120 Tablets per bottle, Once Daily,January 31, 2024
- FDAMesalamine Delayed-Release Tablets, USP 1.2 gram, 120 tablets per bottle, Rx Only, Manufactured by: ActavisNovember 18, 2020
- FDADesoximetasone Topical Spray, 0.25%, 2.5 mg desoximetasone, 100 mL bottles, Rx only, Manufactured for: LupinMarch 11, 2020
- FDAMicroVention Terumo Microplex 10, Platinum Coil System, Endovascular Embolization Coil, HyperSoft Helical,March 4, 2020
- FDAMicroVention Terumo Microplex 10, Platinum Coil System, Endovascular Embolization Coil, Compass 10, Sterile,March 4, 2020
Questions about this recall
Was Mesalamine Delayed-Release Tablets, USP, 1.2 gram, 120-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054; NDC 0591-2245-22. recalled?
Yes. FDA published recall D-0862-2020 on March 11, 2020. Reported hazard: Failed Dissolution Specifications: Low out of specification dissolution result observed during stability testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MESALAMINE. UPC: 0305912245229.